Alibaba has shed 21% over the past month, yet the analyst community remains firmly bullish — a gap between price action and Street conviction that defines the stock's setup heading into August earnings.
The price deterioration has been swift. BABA closed at $102.60 on Tuesday, down another 2.3% on the day and 7.5% on the week. The move lower has compressed valuation multiples visibly: the P/E has contracted by roughly 3.2 points over 30 days to 13.6x, and EV/EBITDA has pulled back nearly 0.4 turns to 8.98x. Those are not distressed levels, but they reflect a market unwilling to pay up for a name carrying margin uncertainty and China macro risk. The price-to-book of 1.42x, down 0.32 turns in a month, adds to the picture of a valuation that has been steadily deflated.
The clearest divergence is between the falling price and what the Street is willing to say publicly. After last quarter's results in May, analysts at JP Morgan, Barclays, Mizuho, and Susquehanna all raised price targets — JP Morgan to $205, Barclays to $195, Mizuho to $195, and Susquehanna to $185. The consensus skew is overwhelmingly positive, with the bull case centred on 15% organic revenue growth, a 20% rise in daily active users following the integration of instant commerce into Taobao, and revised upward revenue forecasts of RMB 1,036 billion for FY26. The bear case pushes back hard on margins: e-commerce EBITA guidance was trimmed, EBITDA missed consensus at RMB 17 billion versus an expected RMB 19 billion, and free cash flow turned negative as investment in quick commerce and cloud infrastructure accelerated. Analyst targets cluster in the $185–$205 range; at $102.60, the implied upside is substantial, but that gap has been wide before without closing quickly. Note that the mean price target in the raw data appears to reflect a Hong Kong-listed ADR conversion anomaly and has been set aside in favour of the individual firm targets cited directly.
Positioning in the lending market is notable mainly for its calm. Availability has loosened meaningfully this week, rising to 107% — roughly one share available for every one already borrowed — after spending most of mid-June in the 97%–127% range. That loosening follows a broader easing trend from the late-May tighter readings in the 77%–87% range. Borrow cost ticked up 28% on the week to 0.46%, but that figure remains historically low; the absolute level is barely worth shorting around. Short interest itself has edged just 0.5% higher on the week to approximately 38.8 million shares, a near-flat reading over a month in which the stock fell more than a fifth. Shorts are not piling in despite the price decline. Options tell a similar story: the put/call ratio dropped to 0.59, a full standard deviation below its 20-day average of 0.63, suggesting call positioning is actually running above recent norms even as the stock sells off. That is an unusual combination — a falling stock with call-heavy options positioning and flat short interest.
The ORTEX short score of 51 sits squarely at the median, consistent with nothing particularly aggressive happening in the borrow market. Factor scores add texture: EPS surprise ranks in the 97th percentile of the universe, and 90-day EPS momentum ranks at the 92nd — the company has been consistently beating estimates. The dividend score of 88 and forward EPS growth rank of 66 round out a fundamental picture that looks more solid than the recent price action implies. The weakest reads are in short-score rank (24th percentile) and days-to-cover rank (28th), which simply reflect that positioning is light relative to history.
Peer context reinforces the selling pressure as broad rather than BABA-specific. JD fell 8.9% on the week, PDD dropped 8.4%, and MNSO lost 11.2%. The entire Chinese consumer internet complex has been under pressure in tandem, which argues against reading the BABA move as a company-specific deterioration. The next scheduled catalyst is the August 13 earnings release; the two prior prints produced a 4.7% gap up and a 9.1% gap down respectively, a reminder that the stock can move sharply in either direction on results.
What to watch into August: whether the gap between analyst targets near $185–$205 and the current price near $103 narrows through either a stock recovery or a fresh round of target cuts — and whether availability, currently loose at 107%, begins to tighten again as the earnings date approaches.
See the live data behind this article on ORTEX.
Open BABA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
